Supply of Tetanus and Diphtheria Toxoids Vaccine

The contract entails the manufacture or supply of a single package of Tetanus and Diphtheria Toxoids, Adsorbed, identified by NSN 6505016632617, to meet stringent FDA and Department of Defense standards. The vaccine is intended for delivery to a government-designated location, ensuring compliance with federal healthcare and military immunization protocols. The effort is structured as a subcontract under the broader procurement framework managed by the Defense Logistics Agency, part of the Department of Defense, with the North American Industry Classification System code 325412 indicating alignment with pharmaceutical and biological product manufacturing. The solicitation was posted on July 16, 2026, and corresponds to the contract number SPE2DX25D8022 with delivery order SPE2D926F7408. Although no specific place of performance or point of contact is provided, the requirement mandates adherence to regulatory and operational benchmarks set by federal authorities. The contract does not include a set-aside designation, indicating it is open to all qualified vendors without restricted eligibility. The official record and details are accessible through the DIBBS portal, underscoring the government’s transparent procurement process for critical medical supplies.